Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Carmela Pera

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Archives of Disease in Childhood|May 16, 2022
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patientsBeatrice Berti, Lavinia Fanelli, Giulia Stanca, et al.
Scientific Reports|July 24, 2025
Neurodevelopmental and mental disorders in children with type I and presymptomatic spinal muscular atrophyBianca Buchignani, Giorgia Coratti, Chiara Cutrì, et al.
Plos One|March 24, 2020
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?Maria Carmela Pera, Giorgia Coratti, Beatrice Berti, et al.
Journal of the Neurological Sciences|March 4, 2026
Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in ItalyStefania Corti, Giulio Gadaleta, Ilaria Bitetti, et al.
Plos One|August 6, 2016
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular DystrophyEugenio Mercuri, Giorgia Coratti, Sonia Messina, et al.
European Journal of Neurology|July 15, 2022
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatmentEugenio Mercuri, Giovanni Baranello, Odile Boespflug-Tanguy, et al.
Neuromuscular Disorders : NMD|March 28, 2021
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measureValeria A Sansone, Alice Pirola, Andrea Lizio, et al.
Journal of Neurology|November 29, 2019
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patientsClaudia Brogna, Lara Cristiano, Tommaso Verdolotti, et al.
European Journal of Pediatrics|May 6, 2022
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screeningMarika Pane, Maria Alice Donati, Costanza Cutrona, et al.
Annals of Clinical and Translational Neurology|May 14, 2025
Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center StudyFiorella Piemonte, Sara Petrillo, Anna Capasso, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Archives of Disease in Childhood|May 16, 2022
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patientsBeatrice Berti, Lavinia Fanelli, Giulia Stanca, et al.
Scientific Reports|July 24, 2025
Neurodevelopmental and mental disorders in children with type I and presymptomatic spinal muscular atrophyBianca Buchignani, Giorgia Coratti, Chiara Cutrì, et al.
Plos One|March 24, 2020
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?Maria Carmela Pera, Giorgia Coratti, Beatrice Berti, et al.
Journal of the Neurological Sciences|March 4, 2026
Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in ItalyStefania Corti, Giulio Gadaleta, Ilaria Bitetti, et al.
Plos One|August 6, 2016
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular DystrophyEugenio Mercuri, Giorgia Coratti, Sonia Messina, et al.
European Journal of Neurology|July 15, 2022
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatmentEugenio Mercuri, Giovanni Baranello, Odile Boespflug-Tanguy, et al.
Neuromuscular Disorders : NMD|March 28, 2021
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measureValeria A Sansone, Alice Pirola, Andrea Lizio, et al.
Journal of Neurology|November 29, 2019
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patientsClaudia Brogna, Lara Cristiano, Tommaso Verdolotti, et al.
European Journal of Pediatrics|May 6, 2022
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screeningMarika Pane, Maria Alice Donati, Costanza Cutrona, et al.
Annals of Clinical and Translational Neurology|May 14, 2025
Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center StudyFiorella Piemonte, Sara Petrillo, Anna Capasso, et al.
Pageof 9